Boston Scientific Stock
Boston Scientific Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Michael F. Mahoney
- Employees
- 59,000
- Market cap
- $64.3 B
- IPO
- 19/05/1992
Boston Scientific Corporation is a global leader in the healthcare sector, specializing in the design, manufacturing, and commercialization of innovative medical technology. Founded in 1979, the company is headquartered in Marlborough, USA. The business is strategically organized into three principal segments:…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Boston Scientific stock: price history
1D
+0.6%
1W
+3.9%
1M
+1.1%
6M
-30.9%
YTD
-53.4%
1Y
-54.6%
2Y
-49.0%
5Y
+2.3%
10Y
+93.4%
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~23% stronger price swings than usual
Boston Scientific stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Boston Scientific
Analyst assessment of Boston Scientific
PRICE TARGET LOW
US$48.00
CONSENSUS
US$61.48
MEDIAN
US$60.00
PRICE TARGET HIGH
US$100.00
1
STRONG BUY
36
BUY
7
HOLD
0
SELL
0
STRONG SELL
44
TOTAL · Buy
As of: 14/10/2026
Boston Scientific stock metrics
P/E
17.9
P/B
2.63
EV/EBITDA
13.17
RETURN ON EQUITY
3.6%
NET MARGIN
16.7%
DEBT/EQUITY
0.51
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.7%
FLOAT SHARES
1,444,983,283
AVG. DAILY VOLUME (30D)
19,205,415
Insider transactions (SEC)
O'Connor Padraig Andrew
O'Connor Padraig Andrew
Morano Susan E
Woodworth Emily
Monson Jonathan
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.6%
Forums (Reddit)
See the full forum history with Pro.
Institutional holders
Dividends & Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Boston Scientific stock
What does Boston Scientific do?
Boston Scientific Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Michael F. Mahoney, the company employs around 59,000 people.
The IPO was on 19/05/1992; the stock trades on NYSE under the ticker BSX.
What do analysts say about Boston Scientific stock?
44 analysts rate the stock, the consensus is Buy (as of 14/10/2026).
The average price target is US$61.48, ranging from US$48.00 to US$100.00, with a median of US$60.00.
This is an external assessment, not a statement by Market Jury.
When does Boston Scientific report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 23% stronger than usual.
Does Boston Scientific pay a dividend?
No, Boston Scientific currently does not pay a dividend.
Which stocks are comparable to Boston Scientific?
Comparable stocks include Abbott Laboratories, Stryker, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings, Align Technology and Bio-Rad Laboratories.
How can I get Boston Scientific stock analyzed?
Clicking "Analyze stock" lets five strategies assess Boston Scientific against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.